Raman Singh
Director/Board Member at LIQUIDIA CORPORATION
Net worth: - $ as of 2024-05-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stephen Bloch | M | 62 |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 15 years |
| Arthur Kirsch | M | 72 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 8 years |
| Damian deGoa | M | 45 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 4 years |
| Katherine Rielly-Gauvin | F | 61 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 5 years |
| Joanna Horobin | M | 69 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 5 years |
| Roger Jeffs | M | 62 | 4 years | |
| Phil Thomson | M | - | 13 years | |
| Seth A. Rudnick | M | 75 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 16 years |
| Emma Walmsley | F | 55 | 14 years | |
| Paul Manning | M | 68 | 4 years | |
| Tushar Shah | M | 64 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 4 years |
| Robert Lippe | M | 59 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 9 years |
| Russell Schundler | M | 49 | 3 years | |
| Michael Kaseta | M | 48 | 4 years | |
| Steven Bariahtaris | M | 60 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 4 years |
| David Johnson | M | 41 | 3 years | |
| Frannie DeFranco | F | - | 14 years | |
| Rajeev Saggar | M | 50 | 2 years | |
| Scott Moomaw | M | 54 | 4 years | |
| María Cristina de Luna Basagoiti | F | - | 14 years | |
| Florina Gordon-Krawchick | F | 42 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 14 years |
| Yu-Seok Jung | M | - |
Abbott Korea Ltd.
 Abbott Korea Ltd. Medical DistributorsDistribution Services Abbott Korea Ltd. engages in the distribution of medical equipment, reagents, medicines, nutritional products, infant formula and baby foods. The company was founded on May 24, 1988 and is headquartered in Seoul, South Korea. | 19 years |
| Jason Adair | M | - |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 8 years |
| Victoria Whyte | F | - | 15 years | |
| Anita Kidgell | F | - | 16 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Thomas Mount | M | - | 7 years | |
| Jean-Pierre Garnier | M | 75 | 8 years | |
| Krishna Boddu | M | 58 |
Osmania University
| 6 years |
| Ian Maurice Gray Prosser | M | 81 | 9 years | |
| James Murdoch | M | 50 | 3 years | |
| Geeta Goti | F | - |
Osmania University
| 9 years |
| Gundlapally Reddy | M | - |
Osmania University
| 3 years |
| Shyam Penumaka | M | - |
Osmania University
| 6 years |
| Christopher Viehbacher | M | 64 | 20 years | |
| Neal Fowler | M | 62 | - | |
| Deirdre Connelly | F | 63 | 6 years | |
| Srikanth R. Dasari | M | 53 |
Osmania University
| 4 years |
| Jack Bailey | M | 59 | 10 years | |
| Shirish Tangirala | M | - |
Osmania University
| 4 years |
| Jeri Thomas | F | 63 | - | |
| Biddala Chenna Kesava Reddy | M | - |
Osmania University
| 2 years |
| Mirza Ansar Baig | M | 54 |
Osmania University
| 4 years |
| Ramkishan Rao Mattapalli | M | - |
Osmania University
| 4 years |
| Francis Paul | M | - |
Osmania University
| 2 years |
| Jeffrey Skolnik | M | - | 5 years | |
| Paul-Peter Tak | M | 64 | 7 years | |
| Amrik Basran | M | - | 3 years | |
| Florina Krawchick | F | 42 | 1 years | |
| Prabhu S. P. | M | - |
Osmania University
| 4 years |
| Sanjaykumar K. Gupta | M | 51 |
Osmania University
| 4 years |
| Kimberly Murphy | F | 62 | 8 years | |
| Melissa Beelen | F | - | 12 years | |
| Rama Rao | M | - |
Osmania University
| 4 years |
| Anil Thakur | M | - |
Osmania University
| 4 years |
| Clare Khan | M | 72 | 11 years | |
| Bharat Snwal | M | 48 |
Osmania University
| 4 years |
| Joe McCann | M | 47 | 4 years | |
| Rajender Juvvadi Rao | M | - |
Osmania University
| 4 years |
| Joy Abraham Rajan | F | 56 |
Osmania University
| 1 years |
| Ravi Namboori | M | - |
Osmania University
| 3 years |
| Laxminath Gopisetty | M | - |
Osmania University
| 4 years |
| Thyagi Thyagarajan | M | - | 38 years | |
| Kiran Kalluri | M | - |
Osmania University
| 4 years |
| Andrew Milne | M | 50 | 1 years | |
| Ramesh Kumar Bikki | M | - |
Osmania University
| 1 years |
| Lon Cardon | M | 58 | 9 years | |
| Russell Greig | M | 71 | 7 years | |
| Ajit Shridhar Shriram | M | 56 |
Osmania University
| 4 years |
| Kishore Ganji | M | - |
Osmania University
| 4 years |
| Simon Harford | M | 63 | 8 years | |
| Elyse G. Seltzer | M | 59 | 6 years | |
| Kavita Prasad Mikkelineni | F | 52 |
Osmania University
| 4 years |
| Satish Kallam Reddy | M | 56 |
Osmania University
| 4 years |
| Richard D. Katz | M | 60 | 1 years | |
| Abburi Vidyasagar | M | 63 |
Osmania University
| 2 years |
| Marc Dunoyer | M | 71 | 3 years | |
| Srini Pajjuri | M | - |
Osmania University
| 4 years |
| Venu Shamapant | M | 56 |
Osmania University
| 4 years |
| Shashi Mehrotra | M | - |
Osmania University
| 4 years |
| Ralph Snyderman | M | 84 | - | |
| Ronaldo Hermann Schmitz | M | 85 | 9 years | |
| Annette Clancy | F | 70 | 30 years | |
| Jayant Aphale | M | 63 | - | |
| Sharad Sinha | M | - |
Osmania University
| 4 years |
| Venkat Kavarthapu | M | - |
Osmania University
| 4 years |
| Vincent O'Neill | M | 55 | 3 years | |
| Gregg Brandyberry | M | - | 16 years | |
| Ravi Vedantam | M | - |
Osmania University
| 4 years |
| Catherine Sohn | M | 71 | 28 years | |
| Paolo Augusto Paoletti | M | 73 | 7 years | |
| Anne Michelle Whitaker | F | 56 | 3 years | |
| Bing Li | M | 55 | 4 years | |
| Kiran Kumar Grandhi | M | 48 |
Osmania University
| 4 years |
| Anu Rao | F | - |
Osmania University
| 4 years |
| Roger Xie | M | 54 | 1 years | |
| Chandra Sekhar Pattapurathi | M | 47 |
Osmania University
| 4 years |
| Suresh Vilayanur | M | - |
Osmania University
| 4 years |
| Carol Ashe | F | 66 | 13 years | |
| Shah Hussain | M | 59 | 9 years | |
| Shagoofa Khan | F | - |
Osmania University
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 39 | 39.00% |
| India | 37 | 37.00% |
| United States | 23 | 23.00% |
| South Korea | 1 | 1.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Raman Singh
- Personal Network
